BU study reveals key to combating high-risk neuroblastoma

The abor­tion drug mifepri­s­tone is once again fac­ing court-im­posed re­stric­tions as a fed­er­al Fifth Cir­cuit Court of Ap­peals ruled Wednes­day that un­til fi­nal judg­ment, the

The FDA is clar­i­fy­ing in­stances where gener­ic drug ap­pli­cants can re­quest that the agency re­con­sid­er an ap­pli­ca­tion, ac­cord­ing to an up­dat­ed draft guid­ance pub­lished Wednes­day.

Mod­er­na said in June that it was “qua­dru­pling down” on rare dis­ease. Right now, that looks like nine or so INDs in the plan­ning phase